| 摘要 |
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases. |
| 申请人 |
INCYTE HOLDINGS CORPORATION |
发明人 |
LI, YUN-LONG;YAO, WENQING;COMBS, ANDREW, P.;YUE, EDDY, W.;MEI, SONG;ZHU, WENYU;GLENN, JOSEPH;MADUSKUIE, THOMAS, P., JR.;SPARKS, RICHARD, B.;DOUTY, BRENT;HE, CHUNHONG |
